Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Share:

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2023, Vol. 28 ›› Issue (8): 910-917.doi: 10.12092/j.issn.1009-2501.2023.08.007

Previous Articles     Next Articles

Research progress on diagnosis and treatment of granulomatous lobular mastitis

WANG Chaoyi, SONG Qiang, XIONG Xin, WANG Mengyuan   

  1. Department of Breast Surgery, Chongqing University Three Gorges Hospital, Chongqing 404100, China
  • Received:2022-09-26 Revised:2023-04-03 Online:2023-08-26 Published:2023-08-29

Abstract:

Granulomatous lobular mastitis (GLM) is a rare form of chronic inflammatory breast disease which may be sometimes difficult to distinguish from breast cancer. The cause of GLM is unknown, but may be associated with autoimmunity, abnormal hormone levels and infection. While GLM has no specific clinical manifestations, the diagnosis is principally established by histopathology. Therapeutic options for GLM range from observation to various medical treatments, such as steroids, immunosuppressants, and antibiotics, to surgical intervention. However, there are still many difficulties in the clinical diagnosis and treatment of GLM, and there is still no unified diagnosis and treatment consensus. So, we accomplished the present review through reviewing GLM-related domestic and foreign literature, aiming to provide the basis for rational clinical diagnosis and treatment. 

Key words: granulomatous lobular mastitis, pathogenesis, clinical manifestation, diagnosis and treatment

CLC Number: